Viemed Healthcare
Market Cap
€329.8m
Last Updated
2021/04/14 19:14 UTC
Data Sources
Company Financials +
Executive Summary
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. More Details
Rewards
Risk Analysis
Earnings are forecast to decline by an average of 40.4% per year for the next 3 years
Snowflake Analysis
Flawless balance sheet with solid track record.
Share Price & News
How has Viemed Healthcare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: VIJ is more volatile than 75% of German stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: VIJ's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
Market Performance
7 Day Return
-4.7%
VIJ
0.9%
DE Healthcare
0.2%
DE Market
1 Year Return
47.7%
VIJ
0.6%
DE Healthcare
42.4%
DE Market
Return vs Industry: VIJ exceeded the German Healthcare industry which returned 0.6% over the past year.
Return vs Market: VIJ exceeded the German Market which returned 42.4% over the past year.
Shareholder returns
| VIJ | Industry | Market | |
|---|---|---|---|
| 7 Day | -4.7% | 0.9% | 0.2% |
| 30 Day | -3.0% | 5.2% | 5.1% |
| 90 Day | 13.1% | -2.9% | 9.6% |
| 1 Year | 47.7%47.7% | 2.6%0.6% | 47.0%42.4% |
| 3 Year | n/a | -27.9%-31.4% | 23.5%12.8% |
| 5 Year | n/a | -28.5%-33.1% | 51.0%29.5% |
Long-Term Price Volatility Vs. Market
How volatile is Viemed Healthcare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Valuation
Is Viemed Healthcare undervalued compared to its fair value and its price relative to the market?
12.27x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: VIJ (€8.2) is trading above our estimate of fair value (€4.17)
Significantly Below Fair Value: VIJ is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: VIJ is good value based on its PE Ratio (12.3x) compared to the DE Healthcare industry average (32.5x).
PE vs Market: VIJ is good value based on its PE Ratio (12.3x) compared to the German market (28.2x).
Price to Earnings Growth Ratio
PEG Ratio: VIJ's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: VIJ is overvalued based on its PB Ratio (4.8x) compared to the DE Healthcare industry average (1.7x).
Future Growth
How is Viemed Healthcare forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
-40.4%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VIJ's earnings are forecast to decline over the next 3 years (-40.4% per year).
Earnings vs Market: VIJ's earnings are forecast to decline over the next 3 years (-40.4% per year).
High Growth Earnings: VIJ's earnings are forecast to decline over the next 3 years.
Revenue vs Market: VIJ's revenue (12.9% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: VIJ's revenue (12.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VIJ's Return on Equity is forecast to be high in 3 years time
Past Performance
How has Viemed Healthcare performed over the past 5 years?
34.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: VIJ has a large one-off gain of $5.8M impacting its December 31 2020 financial results.
Growing Profit Margin: VIJ's current net profit margins (24%) are higher than last year (10.6%).
Past Earnings Growth Analysis
Earnings Trend: VIJ's earnings have grown significantly by 34% per year over the past 5 years.
Accelerating Growth: VIJ's earnings growth over the past year (268.8%) exceeds its 5-year average (34% per year).
Earnings vs Industry: VIJ earnings growth over the past year (268.8%) exceeded the Healthcare industry 2%.
Return on Equity
High ROE: VIJ's Return on Equity (38.6%) is considered high.
Financial Health
How is Viemed Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: VIJ's short term assets ($47.2M) exceed its short term liabilities ($23.0M).
Long Term Liabilities: VIJ's short term assets ($47.2M) exceed its long term liabilities ($7.9M).
Debt to Equity History and Analysis
Debt Level: VIJ's debt to equity ratio (9.9%) is considered satisfactory.
Reducing Debt: VIJ's debt to equity ratio has reduced from 16.2% to 9.9% over the past 5 years.
Debt Coverage: VIJ's debt is well covered by operating cash flow (435.3%).
Interest Coverage: VIJ's interest payments on its debt are well covered by EBIT (41.2x coverage).
Balance Sheet
Dividend
What is Viemed Healthcare current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate VIJ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate VIJ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if VIJ's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if VIJ's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of VIJ's dividend in 3 years as they are not forecast to pay a notable one for the German market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.3yrs
Average management tenure
CEO
Casey Hoyt (43 yo)
3.33yrs
Tenure
US$2,167,644
Compensation
Mr. Casey Hoyt has been Director of Viemed Healthcare, Inc. since December 14, 2016 and serves as Chief Executive Officer. Mr. Hoyt served as Chief Executive Officer of Patient Home Monitoring Corp. from ...
CEO Compensation Analysis
Compensation vs Market: Casey's total compensation ($USD2.17M) is above average for companies of similar size in the German market ($USD922.49K).
Compensation vs Earnings: Casey's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: VIJ's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
Experienced Board: VIJ's board of directors are considered experienced (3.3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.8%.
Top Shareholders
Company Information
Viemed Healthcare, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Viemed Healthcare, Inc.
- Ticker: VIJ
- Exchange: DB
- Founded: 2006
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: CA$494.914m
- Listing Market Cap: CA$329.819m
- Shares outstanding: 39.56m
- Website: https://www.viemed.com
Number of Employees
Location
- Viemed Healthcare, Inc.
- 625 East Kaliste Saloom Road
- Lafayette
- Louisiana
- 70508
- United States
Listings
Biography
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/04/14 19:14 |
| End of Day Share Price | 2021/04/14 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.